SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-025565
Filing Date
2024-08-08
Accepted
2024-08-08 16:17:30
Documents
20
Period of Report
2024-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20240807_8k.htm   iXBRL 8-K 42296
2 EXHIBIT 3.1 ex_710132.htm EX-3.1 3406
3 EXHIBIT 10.1 ex_710133.htm EX-10.1 49445
8 pcert_page1.jpg GRAPHIC 314313
9 pcert_page2.jpg GRAPHIC 309553
10 pcert_page3.jpg GRAPHIC 308406
11 pcert_page4.jpg GRAPHIC 164188
  Complete submission text file 0001437749-24-025565.txt   1757126

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pirs-20240807.xsd EX-101.SCH 3408
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20240807_def.xml EX-101.DEF 11803
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20240807_lab.xml EX-101.LAB 15847
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20240807_pre.xml EX-101.PRE 12018
22 EXTRACTED XBRL INSTANCE DOCUMENT pirs20240807_8k_htm.xml XML 2968
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 241188653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)